NP / PA
Santillan Jimenez, Nancy
Santillan Jimenez, Nancy was paid $749K by Medicaid between Jan 2018 and Oct 2024, across 31 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 41% of everything it billed.
33Billing provider infoSANTILLAN JIMENEZ, NANCY
EDINBURG, TX 78539
EDINBURG, TX 78539
33aNPI1316259591assigned 07/05/2010
33bProvider typeFamily Nurse Practitioner
28Total paid$749K
24GClaims27,774
24DCodes billed31
24AFirst – last monthJan 2018 – Oct 2024
Compared with peers
Next to other Family Nurse Practitioner providers in Texas
Rank by total paid#18 of 344
Median peer was paid$14K
This provider vs. median54×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 220 | $7K | |
| 2019 | 313 | $11K | |
| 2020 | 909 | $22K | |
| 2021 | 5,870 | $146K | |
| 2022 | 6,347 | $165K | |
| 2023 | 7,618 | $210K | |
| 2024incomplete | 6,497 | $189K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 41% | 8,935 | 6,880 | $306K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 25% | 3,801 | 3,149 | $185K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 6.2% | 643 | 627 | $47K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.2% | 517 | 512 | $39K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 4.1% | 2,905 | 1,274 | $31K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 2.5% | 273 | 260 | $19K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 2.5% | 465 | 426 | $19K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2.3% | 263 | 259 | $17K |
| 92557 | 2.2% | 556 | 553 | $17K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.1% | 1,194 | 1,108 | $16K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.0% | 1,098 | 523 | $15K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,019 | 948 | $7K |
19 more codes
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 878 | $7K |
| 92552 | <1% | 248 | $6K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 113 | $5K |
| 99429 | <1% | 166 | $4K | |
| 99051 | <1% | 285 | $4K | |
| 92551 | <1% | 371 | $3K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 125 | $1K |
| 90461 | <1% | 2,004 | $1K | |
| 81003 | <1% | 221 | $406.35 | |
| 96160 | <1% | 408 | $223.84 | |
| 87807 | <1% | 13 | $143.00 | |
| 96161 | <1% | 758 | $115.18 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 14 | $7.14 |
| 90686 | <1% | 227 | $0.10 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 53 | $0.00 |
| 96127 | 0% | 26 | $0.00 | |
| 90656 | 0% | 12 | $0.00 | |
| 90670 | 0% | 103 | $0.00 | |
| 90648 | 0% | 80 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.